Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - Breathe, 2015 - Eur Respiratory Soc
Key points There have been significant advances in both inhalation medicines and delivery
devices with “intelligent nebulisers” and “dry-powder inhalers” becoming commonplace in …
devices with “intelligent nebulisers” and “dry-powder inhalers” becoming commonplace in …
Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - Breathe (Sheffield, England), 2015 - pubmed.ncbi.nlm.nih.gov
Key points There have been significant advances in both inhalation medicines and delivery
devices with" intelligent nebulisers" and" dry-powder inhalers" becoming commonplace in …
devices with" intelligent nebulisers" and" dry-powder inhalers" becoming commonplace in …
Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - Breathe, 2015 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Key points</jats: title>< jats: list list-type=" bullet">< jats: list-
item>< jats: p> There have been significant advances in both inhalation medicines and …
item>< jats: p> There have been significant advances in both inhalation medicines and …
[HTML][HTML] Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - Breathe, 2015 - ncbi.nlm.nih.gov
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral
medications, airway clearance and optimised nutrition. This review discusses recent …
medications, airway clearance and optimised nutrition. This review discusses recent …
[PDF][PDF] Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - researchgate.net
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral
medications, airway clearance and optimised nutrition. This review discusses recent …
medications, airway clearance and optimised nutrition. This review discusses recent …
Inhaled therapy in cystic fibrosis: agents, devices and regimens.
P Agent, H Parrott - Breathe, 2015 - search.ebscohost.com
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral
medications, airway clearance and optimised nutrition. This review discusses recent …
medications, airway clearance and optimised nutrition. This review discusses recent …
Inhaled therapy in cystic fibrosis: agents, devices and regimens.
P Agent, H Parrott - Breathe (Sheffield, England), 2015 - europepmc.org
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral
medications, airway clearance and optimised nutrition. This review discusses recent …
medications, airway clearance and optimised nutrition. This review discusses recent …
[PDF][PDF] Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - Citeseer
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral
medications, airway clearance and optimised nutrition. This review discusses recent …
medications, airway clearance and optimised nutrition. This review discusses recent …
[PDF][PDF] Inhaled therapy in cystic fibrosis: agents, devices and regimens
P Agent, H Parrott - cyberleninka.org
The recognised mainstay daily treatments for cystic fibrosis (CF) focus on inhaled and oral
medications, airway clearance and optimised nutrition. This review discusses recent …
medications, airway clearance and optimised nutrition. This review discusses recent …